The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting.

Trial Profile

The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2011

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Left ventricular dysfunction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Sep 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
    • 20 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top